FAIRBAIRN EMILY → IN8BIO, INC. INAB

Stake: 2.20% Shares: 215,431 CUSIP: 45674E208 Class: Common Stock, $0.0001 par value per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 18/100

Active Schedule 13D filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

32,797 shares short · -29.4% vs prior

Post-Filing Returns · since 2026-05-27 on INAB

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

-14.4%

+90 days

—

+180 days

—

Anchor price 1.39 on closest trading day on/after 2026-05-27. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on IN8BIO, INC.

Filed	Form	Filer	Stake	Shares
2025-12-29	SCHEDULE	BIOS Fund II, LP	4.00%	391,357	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →